Table 1 Characteristics of the included studies
Characteristics | Number | Percent |
|---|---|---|
Publication years | ||
 Before 2000 | 9 | 15.52 |
 2000–2009 | 26 | 44.83 |
 2010–2022 | 23 | 39.66 |
Continents | ||
 Asia | 1 | 1.72 |
 Europe | 27 | 46.5 |
 North America | 30 | 51.72 |
Study designs | ||
 Case reports/Case series | 4 | 6.89 |
 Cohort studies | 2 | 3.45 |
 Cross-sectional studies | 34 | 58.62 |
 Prospective observational studies | 4 | 6.90 |
 Retrospective observational studies | 14 | 24.14 |
Plasmodium species | ||
 P. falciparum only | 14 | 24.04 |
 P. vivax only | 1 | 1.7 |
 P. falciparum and other species | 43 | 74.14 |
Age groups | ||
 Children | 1 | 1.72 |
 Adults | 15 | 25.26 |
 Children and adults | 1 | 1.72 |
 All age groups | 34 | 58.62 |
 Not specified | 7 | 12.07 |
Diagnostic methods for malaria | ||
 Microscopy | 28 | 48.28 |
 Microscopy or PCR | 2 | 3.4 |
 Microscopy or RDT | 6 | 10.34 |
 Microscopy or RDT or PCR | 8 | 13.79 |
 Hospital physicians | 1 | 1.72 |
 Not specified | 13 | 22.41 |